Our DNA-seq analysis of 76,639 pan-cancer samples identified 31 DDR/FA signaling genes, with ataxia-telangiectasia mutated (ATM) showing the highest mutation rate at 5%, followed by BRCA2/FANCD1 at 4%. This evidence concerns the gene BRCA2 and cancer.